Article

Formulary Exclusion List Savings Analysis Highlights AJPB Week in Review

Author(s):

Davy James, Managing Editor

Top articles of the week from The American Journal of Pharmacy Benefits.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Related Content
hands holding pink ribbons, Breast cancer awareness and October Pink day, world cancer day | Image Credit: Sewcream Studio | adobe.stock.com
September 16th 2025

Understanding the Risk of Second Primary Cancers After Early Breast Cancer

Danielle Valletti, Assistant Editor
ESC 2023 Highlights: Insights on ALONE-AF and AQUATIC Trials
September 16th 2025

ESC 2023 Highlights: Insights on ALONE-AF and AQUATIC Trials

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP Aislinn Antrim, Managing Editor
DIGIT-HF: Digitoxin’s Evidence Remains Insufficient for a Digoxin-Level Recommendation
September 16th 2025

DIGIT-HF: Digitoxin’s Evidence Remains Insufficient for a Digoxin-Level Recommendation

Belkis Kaplan, PharmD Resident
Pharmacy focus oncology Edition, radon and lung cancer
September 16th 2025

A Silent Killer: Unmasking Radon’s Link to Lung Cancer

Alexandra Gerlach, Associate Editor
Compression socks with edema therapy concept. Futuristic socks with glowing patterns showcasing foot anatomy.
September 16th 2025

FDA Approves Bumetanide Nasal Spray for Edema With Heart Failure, Hepatic and Renal Disease

Luke Halpern, Assistant Editor
Toronto, Canada | Image Credit: © rabbit75_fot - stock.adobe.com
September 16th 2025

International Myeloma Society Annual Meeting: Key Data and Guideline Updates in Multiple Myeloma

Alexandra Gerlach, Associate Editor
© 2025 MJH Life Sciences

All rights reserved.